Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Immunoregulatory Potential of Particle Radiation in Cancer Therapy.
Ebner DK, Tinganelli W, Helm A, Bisio A, Yamada S, Kamada T, Shimokawa T, Durante M. Ebner DK, et al. Among authors: yamada s. Front Immunol. 2017 Feb 6;8:99. doi: 10.3389/fimmu.2017.00099. eCollection 2017. Front Immunol. 2017. PMID: 28220126 Free PMC article.
Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
Okonogi N, Kaminuma T, Okimoto T, Shinoto M, Yamamoto N, Yamada S, Murata K, Ohno T, Shioyama Y, Tsuji H, Nakano T, Kamada T. Okonogi N, et al. Among authors: yamada s. Int J Clin Oncol. 2019 Sep;24(9):1143-1150. doi: 10.1007/s10147-019-01440-y. Epub 2019 Apr 9. Int J Clin Oncol. 2019. PMID: 30968270 Free PMC article. Clinical Trial.
Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments.
Helm A, Ebner DK, Tinganelli W, Simoniello P, Bisio A, Marchesano V, Durante M, Yamada S, Shimokawa T. Helm A, et al. Among authors: yamada s. Int J Part Ther. 2018 Summer;5(1):84-93. doi: 10.14338/IJPT-18-00024.1. Epub 2018 Sep 21. Int J Part Ther. 2018. PMID: 31773022 Free PMC article. Review.
Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
Okonogi N, Usui H, Murata K, Hori M, Kurokawa T, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Hasegawa S, Yamada S, Hanaoka H, Shozu M, Tsuji H. Okonogi N, et al. Among authors: yamada s. BMJ Open. 2022 Mar 2;12(3):e056424. doi: 10.1136/bmjopen-2021-056424. BMJ Open. 2022. PMID: 35236732 Free PMC article.
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
Okonogi N, Murata K, Yamada S, Habu Y, Hori M, Kurokawa T, Inaba Y, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Koto M, Hasegawa S, Ishikawa H, Hanaoka H, Shozu M, Tsuji H, Usui H. Okonogi N, et al. Among authors: yamada s. Int J Mol Sci. 2023 Jun 23;24(13):10565. doi: 10.3390/ijms241310565. Int J Mol Sci. 2023. PMID: 37445743 Free PMC article. Clinical Trial.
8,295 results